Recurrent MGMT-Methylated Glioblastoma Clinical Trials in Chicago, Illinois

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment